RETRACTED: EGFR as a transcription factor?

Author： Wong R.W.C.   Chan S.Y.  

Publisher： Elsevier

ISSN： 1043-2760

Source： Trends in Endocrinology and Metabolism, Vol.12, Iss.10, 2001-12, pp. : 431-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Effects of EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibodies

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 8, Iss. 3, 2010-07 ,pp. : 156-163

Bentham Science Publishers

Access to resources Recommend Favorite

Transcription Factor-Targeted Therapies in Inflammatory Bowel Disease

By  

Digestion, Vol. 63, Iss. 1, 2001-01 ,pp. : 68-72

Karger

Access to resources Recommend Favorite

The Role of the Transcription Factor Nuclear Factor Kappa B in the Regulation of Cardiac Hypertrophy

By Sorriento Daniela   Iaccarino Guido   Trimarco Bruno  

High Blood Pressure & Cardiovascular Prevention, Vol. 17, Iss. 4, 2010-12 ,pp. : 209-217

Adis International

Access to resources Recommend Favorite

RETRACTED ARTICLE: Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells

By Kalishwaralal Kalimuthu  

Angiogenesis, Vol. 14, Iss. 1, 2011-03 ,pp. : 29-45

Springer Publishing Company

Access to resources Recommend Favorite

Egr-1 is a Major Vascular Pathogenic Transcription Factor in Atherosclerosis and Restenosis

By Blaschke Florian   Bruemmer Dennis   Law Ronald E.  

Reviews in Endocrine and Metabolic Disorders, Vol. 5, Iss. 3, 2004-08 ,pp. : 249-254

Springer Publishing Company

Access to resources Recommend Favorite